Risk of atrioventricular block during adenosine pharmacologic stress testing in heart transplant recipients

American Journal of Cardiology

Volumn 82, Issue 5, 1998, Pages 696-697

  Toft, Jens ^a   Mortensen, Jann ^a   Hesse, Birger ^a  

^a Mental Health Services CPH   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE; AMLODIPINE; DIPYRIDAMOLE; FELODIPINE; FUROSEMIDE; NIFEDIPINE;

ADOLESCENT; ADULT; ARTICLE; ATRIOVENTRICULAR BLOCK; AUTONOMIC DENERVATION; CARDIOVASCULAR RISK; CASE REPORT; DOSE RESPONSE; DRUG MECHANISM; DRUG SAFETY; EXERCISE TEST; FEMALE; HEART MUSCLE PERFUSION; HEART TRANSPLANTATION; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; PAROXYSMAL SUPRAVENTRICULAR TACHYCARDIA; PRIORITY JOURNAL;

ADENOSINE; ADOLESCENT; ADULT; CARDIOVASCULAR AGENTS; DIPYRIDAMOLE; DOSE-RESPONSE RELATIONSHIP, DRUG; EXERCISE TEST; FEMALE; HEART BLOCK; HEART TRANSPLANTATION; HUMANS; INFUSIONS, INTRAVENOUS; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; RISK FACTORS;

EID: 0031679219     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9149(98)00392-0     Document Type: Article

References (12)

1. Ranhosky A, Kempthorne-Rawson J, and the Intravenous Dipyridamole Thallium Imaging Study Group. The safety of intravenous dipyridamole thallium myocardial perfusion imaging. Circulation 1990;81:1205-1209.
2. Cerqueira MD, Verani MS, Schwaiger M, Heo J, Iskandrian AS, and the Investigators of the Multicenter Adenoscan Trial. Safety profile of adenosine stress perfusion imaging: results from the adenoscan multicenter trial registry. J Am Coll Cardiol 1994;23:384-389.
3. Johnston DL, Dailey JR, Hodge DO, Hopfenspirger MR, Gibbons RJ. Hemodynamic responses and adverse effects associated with adenosine and dipyridamole pharmacologic stress testing: a comparison in 2000 patients. Mayo Clin Proc 1995;70:331-336.
4. Lette J, Tatum JL, Fraser S, Miller DD, Waters DD, Heller G, Stanton EB, Bom HS, Leppo J, Nattel S. Safety of dipyridamole testing in 73,806 patients: the multicenter dipyridamole safety study. J Nucl Cardiol 1995;2:3-17.
5. Pennell DJ, Mavrogeni SI, Forbat SM, Karwatowski SP, Underwood SR. Adenosine combined with dynamic exercise for myocardial perfusion imaging. J Am Coll Cardiol 1995;25:1300-1309.
6. Ellenbogen KA, Thames MD, DiMarco JP, Sheehan H, Lerman BB. Electrophysiological effects of adenosine in transplanted human heart. Evidence of supersensitivity. Circulation 1990:81:821-828.
7. Anderson TJ, Ryan TJ, Mudge GH, Selwyn AP, Ganz P, Yeung AC. Sinoatrial and atrioventricular block caused by intracoronary infusion of adenosine early after heart transplantation. J Heart Lung Transplant 1993:12:522-524.
8. O'Nunain S, Bertolet BD, Belardinelli L, Woodard DA, Curtis AB. Effects of adenosine on atrial repolarization in the transplanted human heart. Am J Cardiol 1993:71:248-251.
9. Bertolet BD, Eagle D, Conti JB, Mills RM, Belardinelli L. Bradycardia after heart transplantation: reversal with theophylline. J Am Coll Cardiol 1996;28:396-399.
10. Iskandrian AS. Are differences between adenosine and dipyridamole clinically relevant. J Nucl Cardiol 1996;3:281-283.
11. McLaughlin DP, Beller GA, Linden J, Ayers CR, Ripley ML, Taylor H, Watson DD, Feldman MD. Hemodynamic and metabolic correlates of dipyridamole-induced myocardial thallium-201 perfusion abnormalities in multivessel coronary artery disease. Am J Cardiol 1994;74:1159-1164.
12. Rossen JD, Quillen JE, Lopez JAG, Stenberg RG, Talman CL, Winniford MD. Comparison of coronary vasodilation with intravenous dipyridamole and adenosine. J Am Coll Cardiol 1991;18:485-491.